Shanna Miranti, MPAS, PA-C: Managing the Psychosocial Impact of Vitiligo
Shanna Miranti, MPAS, PA-C, discusses the bimodal distribution of vitiligo in male and female individuals and the necessary counseling for those who are managing their initial diagnosis.
Andrea Nguyen, PA-C, MS: Determining Treatment Goals and Expectations for Patients with Vitiligo
Andrea Nguyen discusses how she counsels patients with vitiligo and emphasizes the importance in communicating with patients about consistent application and dosing during a treatment regimen.
Raj Chovatiya, MD, PhD: Utilizing Ruxolitinib Cream for Patients with Vitiligo
Dr. Chovatiya discusses how to effectively treat patients with nonsegmental vitiligo using topical ruxolitinib cream and the importance in a slow and steady treatment regimen.
Nada Elbuluk, MD, FAAD: Research and Utility of Ruxolitinib Cream for Vitiligo
Dr. Elbuluk discusses results of the clinical trials for ruxolitinib cream in patients with vitiligo and how this treatment is being incorporated into the dermatologist’s vitiligo toolkit.
John Harris, MD, PhD: Effective Treatment for Patients with Vitiligo
John Harris, MD, PhD, Chair of Dermatology at UMass Chan Medical School, discusses the impact topical ruxolitinib cream has had on patients with vitiligo. He explains how this treatment has shown exceptional efficacy with limited side effects.